S 2531 United States Senate · 119th Congress

Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025

This bill directs the U.S. Department of Health and Human Services to fund research on early detection and treatment of uterine fibroids (non-cancerous uterine tumors) and to award grants to states. The grants will support state programs that increase early detection through screening (like advanced imaging), patient navigation services, public education campaigns, and implementing research-backed strategies. It also requires additional research on disparities in pain management during fibroid surgery and conditions like Asherman’s Syndrome. States receiving grants must report on program outcomes and research findings to Congress every two years. The bill directly affects healthcare systems, providers, and patients - particularly those facing disparities in gynecological care - by expanding access to early detection services.
Bill status in committee 1 of 4 stages cleared
Introduction
Jul 2025
Committee Review
Floor Vote
President
Introduced Jul 30, 2025 Last action Mar 19, 2026
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
3
Key actions
1
Committee
2
Mar 19, 2026
Upper · Passed
Committee on Health, Education, Labor, and Pensions. Hearings held.
upper
Jul 30, 2025
Committee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
upper
Jul 30, 2025
Introduced
Introduced in Senate
upper
1 primary · 4 co-sponsors

Sponsors